Skip to main content
In stock | Targeted Therapy

Eltanexor

Oncology Type Hematologic (Multiple Myeloma/DLBCL)
Drug Class / Mechanism XPO1 (Exportin-1) Inhibitor
No Image
Description

Eltanexor is classified as a XPO1 (Exportin-1) Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy
Oncology Type Hematologic (Multiple Myeloma/DLBCL)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3